The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1255 articles
Health Canada acknowledges public demand for cheaper generic options for the popular drug Ozempic. Several companies have filed for authorization, though timelines are unclear. Patients may face delays in accessing these alternatives.
A recent study reveals that GLP-1 medications can significantly decrease severe asthma episodes among adolescents who are overweight or obese. Researchers found a notable reduction in emergency room visits and steroid use. Experts suggest these drugs offer dual benefits for weight control and asthma management.
Singer Jelly Roll achieved remarkable weight loss without relying on medications, choosing instead to address his eating habits as an addiction. He explains the surprising factors behind his decision and the profound impacts on his life. This natural path has revitalized his health and relationships.
Certain batches of Wegovy are being pulled from circulation because hair has been detected in pre-filled syringes. This action ensures patient safety and highlights the importance of quality control in pharmaceutical products. Consumers are advised to check for affected lots.
GLP-1 injectable treatments have surged in popularity in India, prompting medical professionals to emphasize comprehensive diagnostic evaluations before initiating therapy. Key assessments cover metabolic health, organ function, and specific risks to guarantee patient safety. This approach underscores the importance of medical oversight for these potent medications.
In Ohio, Representative Josh Williams is sponsoring House Bill 388 to reimburse state workers for GLP-1 medications purchased directly from manufacturers, bypassing high pharmacy costs. This initiative follows the state's decision to drop coverage in early 2025 due to expenses, with the bill proposing a more affordable reimbursement model. Williams emphasizes that this approach could slash costs while providing stable access to essential health treatments.
Shake Shack is adapting to the rise of GLP-1 medications by launching a new menu focused on protein-rich choices. The Good Fit Menu provides familiar favorites with modifications for easier, more intentional eating. This shift echoes nutritional advice and reflects broader changes in fast food.
Demi Lovato ushered in the new year by showcasing her 22kg weight loss through bikini photos on Instagram. Admirers complimented her physique, and she recounted a significant 2025 involving her wedding and latest album release. During a chat, she detailed her drug-free routine and plans for an energetic tour.
Novo Nordisk starts the trading year with notable progress, including a favorable patent decision in China and the introduction of an oral version of Wegovy in the United States. This dual momentum strengthens the company's stance in key regions while addressing challenges like patent expirations and pricing strategies. Health tracking apps like Shotlee can assist patients in monitoring their progress during such treatments.
